TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Catheter Ablation Versus Medical Treatment of AF in Heart Failure
Brief Summary: Heart failure and atrial fibrillation (AF) often coexist, and each increases the morbidity and mortality associated with the other. The investigators hypothesized that restoration of normal sinus rhythm by catheter ablation is superior to medical treatment of AF in heart failure. This study randomizes patients with heart failure and persistent AF to medical treatment of AF or catheter ablation to restore sinus rhythm.


Options:
A: Arm Label: Catheter Ablation; Type: EXPERIMENTAL; Interventions: Procedure: Catheter ablation of persistent atrial fibrillation | Arm Label: Medical treatment alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Medical treatment alone | Intervention Type: PROCEDURE; Name: Catheter ablation of persistent atrial fibrillation; Assigned to Arm(s): Catheter Ablation | Intervention Type: DRUG; Name: Medical treatment alone; Assigned to Arm(s): Medical treatment alone
B: Arm Label: Rate control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Medication to control ventricular rate in AF | Arm Label: Catheter Ablation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Catheter Ablation for Persistent Atrial Fibrillation | Intervention Type: DRUG; Name: Medication to control ventricular rate in AF; Assigned to Arm(s): Rate control | Intervention Type: PROCEDURE; Name: Catheter Ablation for Persistent Atrial Fibrillation; Assigned to Arm(s): Catheter Ablation
C: Arm Label: Cavo-tricuspid-isthmus-ablation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cavo-tricuspid-isthmus-ablation | Arm Label: Pulmonary vein isolation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Pulmonary vein isolation | Arm Label: Antiarrhythmic drug; Type: ACTIVE_COMPARATOR; Interventions: Drug: Antiarrhythmic drug | Intervention Type: DRUG; Name: Antiarrhythmic drug; Assigned to Arm(s): Antiarrhythmic drug | Intervention Type: PROCEDURE; Name: Cavo-tricuspid-isthmus-ablation; Assigned to Arm(s): Cavo-tricuspid-isthmus-ablation | Intervention Type: PROCEDURE; Name: Pulmonary vein isolation; Assigned to Arm(s): Pulmonary vein isolation
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radiofrequency ablation | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Radiofrequency ablation | Intervention Type: PROCEDURE; Name: Radiofrequency ablation; Assigned to Arm(s): 1, 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Diet on Body Composition
Brief Summary: The purpose of this study is to compare a diet containing whole grains versus an energy matched diet using refined grains on body composition and metabolism.


Options:
A: Arm Label: Low Glycemic Index Diet; Type: EXPERIMENTAL; Interventions: Other: Low Glycemic Index diet | Arm Label: High Fiber Diet; Type: ACTIVE_COMPARATOR; Interventions: Other: High Cereal Fibre Diets | Intervention Type: OTHER; Name: Low Glycemic Index diet; Assigned to Arm(s): Low Glycemic Index Diet | Intervention Type: OTHER; Name: High Cereal Fibre Diets; Assigned to Arm(s): High Fiber Diet
B: Arm Label: Whole grains; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Whole grains | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Whole grains; Assigned to Arm(s): Whole grains
C: Intervention Type: DIETARY_SUPPLEMENT; Name: Ls-33; Assigned to Arm(s): N/A
D: Arm Label: Whole grain diet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Whole grains | Arm Label: Refined grain diet; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Whole grains | Intervention Type: DIETARY_SUPPLEMENT; Name: Whole grains; Assigned to Arm(s): Refined grain diet, Whole grain diet

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Toolkit to Improve Cardiovascular Disease Screening and Treatment for People With Diabetes
Brief Summary: Diabetes is a common and serious chronic disease. However, there is a large gap between the level of care that people should receive (based on research and guidelines) and the level of care they actually receive. With the release of their 2008 Clinical Practice Guidelines, the Canadian Diabetes Association has a strategy to improve heart disease screening and treatment for people with diabetes. This study will evaluate whether the strategy works. The focus of the strategy was to give all family physicians in Canada a Toolkit in June 2009 to help them delivery better care for their diabetic patients. In Ontario, only half of doctors received this Toolkit. We will compare the quality of care received by diabetic patients whose doctors received this Toolkit versus those who doctors did not.


Options:
A: Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse-led case management | Intervention Type: BEHAVIORAL; Name: Nurse-led case management; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): B
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Internet Intervention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Internet Intervention; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control
C: Intervention Type: BEHAVIORAL; Name: Resistance Training; Assigned to Arm(s): N/A
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Toolkit | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: Toolkit; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Toolkit to Improve Cardiovascular Disease Screening and Treatment for People With Diabetes
Brief Summary: Diabetes is a common and serious chronic disease. However, there is a large gap between the level of care that people should receive (based on research and guidelines) and the level of care they actually receive. With the release of their 2008 Clinical Practice Guidelines, the Canadian Diabetes Association has a strategy to improve heart disease screening and treatment for people with diabetes. This study will evaluate whether the strategy works. The focus of the strategy was to give all family physicians in Canada a Toolkit in June 2009 to help them delivery better care for their diabetic patients. In Ontario, only half of doctors received this Toolkit. We will compare the quality of care received by diabetic patients whose doctors received this Toolkit versus those who doctors did not.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Toolkit | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: Toolkit; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: 1; Type: N/A; Interventions: N/A | Arm Label: 2; Type: N/A; Interventions: N/A
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Toolkit | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: Toolkit; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
D: Intervention Type: BEHAVIORAL; Name: Nurse Case Management intervention; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Brief Summary: The objective of this study is to evaluate the efficacy and safety of cariprazine relative to placebo in the prevention of relapse of symptoms in participants with schizophrenia.


Options:
A: Arm Label: Iloperidone; Type: EXPERIMENTAL; Interventions: Drug: Iloperidone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Iloperidone; Assigned to Arm(s): Iloperidone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: asenapine; Type: EXPERIMENTAL; Interventions: Drug: Asenapine - Open Label, Drug: Asenapine - Double Blind | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Asenapine - Open Label, Drug: Placebo - Double Blind | Intervention Type: DRUG; Name: Asenapine - Open Label; Assigned to Arm(s): asenapine, placebo | Intervention Type: DRUG; Name: Placebo - Double Blind; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: Asenapine - Double Blind; Assigned to Arm(s): asenapine
C: Arm Label: Cariprazine - Open-label Phase; Type: EXPERIMENTAL; Interventions: Drug: Cariprazine | Arm Label: Placebo - Double-blind Treatment Phase; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Arm Label: Cariprazine - Double-blind Treatment Phase; Type: EXPERIMENTAL; Interventions: Drug: Cariprazine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo - Double-blind Treatment Phase | Intervention Type: DRUG; Name: Cariprazine; Assigned to Arm(s): Cariprazine - Double-blind Treatment Phase, Cariprazine - Open-label Phase
D: Arm Label: Integrated Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Treatment | Arm Label: Community Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Community Care | Intervention Type: BEHAVIORAL; Name: Integrated Treatment; Assigned to Arm(s): Integrated Treatment | Intervention Type: BEHAVIORAL; Name: Community Care; Assigned to Arm(s): Community Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate the Efficacy and Safety of Ocrelizumab in Comparison to Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
Brief Summary: This randomized, double-blind, double-dummy, parallel-group study will evaluate the efficacy and safety of ocrelizumab in comparison with interferon beta-1a (Rebif) in participants with relapsing multiple sclerosis. Participants will be randomized to receive either ocrelizumab 600 mg or matching placebo intravenous (IV) as 300 mg infusions on Days 1 and 15 for the first dose and as a single infusion of 600 mg for all subsequent infusions every 24 weeks, with placebo injections matching interferon beta-1a SC three times per week; or interferon beta-1a 44 mcg SC injections three times per week (with placebo infusions matching ocrelizumab infusions every 24 weeks).


Options:
A: Arm Label: Interferon beta-1a 44 mcg SC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Interferon beta-1a, Drug: Ocrelizumab-matching placebo | Arm Label: Ocrelizumab; Type: EXPERIMENTAL; Interventions: Drug: Ocrelizumab, Drug: Interferon beta-1a-matching placebo | Intervention Type: DRUG; Name: Interferon beta-1a; Assigned to Arm(s): Interferon beta-1a 44 mcg SC | Intervention Type: DRUG; Name: Ocrelizumab-matching placebo; Assigned to Arm(s): Interferon beta-1a 44 mcg SC | Intervention Type: DRUG; Name: Ocrelizumab; Assigned to Arm(s): Ocrelizumab | Intervention Type: DRUG; Name: Interferon beta-1a-matching placebo; Assigned to Arm(s): Ocrelizumab
B: Arm Label: Fish oil concentrate; Type: EXPERIMENTAL; Interventions: Drug: Fish oil concentrate | Arm Label: Placebo oil; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Fish oil concentrate; Assigned to Arm(s): Fish oil concentrate | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo oil
C: Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Ocrelizumab, Other: Placebo | Arm Label: Ocrelizumab 600 mg; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ocrelizumab | Intervention Type: DRUG; Name: Ocrelizumab; Assigned to Arm(s): Ocrelizumab 600 mg, Placebo | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Polyphenon E 400mg twice a day; Type: EXPERIMENTAL; Interventions: Drug: Polyphenon E | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Polyphenon E; Assigned to Arm(s): Polyphenon E 400mg twice a day | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal Arteries
Brief Summary: The purpose of the study is to demonstrate the superior efficacy and non-inferior safety of the Moxy Drug Coated Balloon by direct comparison to standard percutaneous transluminal angioplasty (PTA) catheter for treatment of stenosis of the femoropopliteal arteries.


Options:
A: Arm Label: Moxy Drug Coated Balloon; Type: EXPERIMENTAL; Interventions: Device: Moxy Drug Coated Balloon | Arm Label: Standard Uncoated Angioplasty Balloon; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Uncoated Angioplasty Balloon | Intervention Type: PROCEDURE; Name: Standard Uncoated Angioplasty Balloon; Assigned to Arm(s): Standard Uncoated Angioplasty Balloon | Intervention Type: DEVICE; Name: Moxy Drug Coated Balloon; Assigned to Arm(s): Moxy Drug Coated Balloon
B: Arm Label: Drug Eluting Balloon; Type: EXPERIMENTAL; Interventions: Device: IN.PACT Amphirion | Arm Label: Standard PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard PTA | Intervention Type: DEVICE; Name: IN.PACT Amphirion; Assigned to Arm(s): Drug Eluting Balloon | Intervention Type: DEVICE; Name: Standard PTA; Assigned to Arm(s): Standard PTA
C: Arm Label: Drug-Coated Balloon (DCB); Type: EXPERIMENTAL; Interventions: Device: Drug-Coated Balloon (DCB) | Arm Label: Standard PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: PTA Balloon: Balloon Angioplasty | Intervention Type: DEVICE; Name: Drug-Coated Balloon (DCB); Assigned to Arm(s): Drug-Coated Balloon (DCB) | Intervention Type: DEVICE; Name: PTA Balloon: Balloon Angioplasty; Assigned to Arm(s): Standard PTA
D: Arm Label: Stent; Type: EXPERIMENTAL; Interventions: Device: Zilver® PTX™ Stent | Intervention Type: DEVICE; Name: Zilver® PTX™ Stent; Assigned to Arm(s): Stent

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Endometrial Scratching in Couples With Unexplained Subfertility
Brief Summary: Endometrial scratching in luteal phase of a spontaneous menstrual cycle may increase pregnancy rate in women with unexplained infertility.


Options:
A: Arm Label: Office hysteroscopy and endometrial snip; Type: EXPERIMENTAL; Interventions: Procedure: Office hysteroscopy and endometrial snip | Arm Label: Office hyteroscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Office hysteroscopy | Intervention Type: PROCEDURE; Name: Office hysteroscopy and endometrial snip; Assigned to Arm(s): Office hysteroscopy and endometrial snip | Intervention Type: PROCEDURE; Name: Office hysteroscopy; Assigned to Arm(s): Office hyteroscopy
B: Arm Label: Endometrial injury group; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial injury | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Procedure: Control group | Intervention Type: PROCEDURE; Name: Endometrial injury; Assigned to Arm(s): Endometrial injury group | Intervention Type: PROCEDURE; Name: Control group; Assigned to Arm(s): Control group
C: Arm Label: clomiphene and endometrial sampling; Type: ACTIVE_COMPARATOR; Interventions: Device: endometrial sampling, Drug: clomiphene citrate | Arm Label: clomiphene citrate; Type: ACTIVE_COMPARATOR; Interventions: Drug: clomiphene citrate | Intervention Type: DEVICE; Name: endometrial sampling; Assigned to Arm(s): clomiphene and endometrial sampling | Intervention Type: DRUG; Name: clomiphene citrate; Assigned to Arm(s): clomiphene and endometrial sampling, clomiphene citrate
D: Arm Label: Scrathcing; Type: EXPERIMENTAL; Interventions: Procedure: scratching | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Procedure: scratching | Intervention Type: PROCEDURE; Name: scratching; Assigned to Arm(s): Control, Scrathcing

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Endometrial Scratching in Couples With Unexplained Subfertility
Brief Summary: Endometrial scratching in luteal phase of a spontaneous menstrual cycle may increase pregnancy rate in women with unexplained infertility.


Options:
A: Arm Label: Scrathcing; Type: EXPERIMENTAL; Interventions: Procedure: scratching | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Procedure: scratching | Intervention Type: PROCEDURE; Name: scratching; Assigned to Arm(s): Control, Scrathcing
B: Arm Label: Pipelle Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Pipelle de Cornier | Arm Label: Explora group; Type: ACTIVE_COMPARATOR; Interventions: Device: Explora curette | Intervention Type: DEVICE; Name: Pipelle de Cornier; Assigned to Arm(s): Pipelle Group | Intervention Type: DEVICE; Name: Explora curette; Assigned to Arm(s): Explora group
C: Arm Label: clomiphene and endometrial sampling; Type: ACTIVE_COMPARATOR; Interventions: Device: endometrial sampling, Drug: clomiphene citrate | Arm Label: clomiphene citrate; Type: ACTIVE_COMPARATOR; Interventions: Drug: clomiphene citrate | Intervention Type: DEVICE; Name: endometrial sampling; Assigned to Arm(s): clomiphene and endometrial sampling | Intervention Type: DRUG; Name: clomiphene citrate; Assigned to Arm(s): clomiphene and endometrial sampling, clomiphene citrate
D: Arm Label: Office hysteroscopy and endometrial snip; Type: EXPERIMENTAL; Interventions: Procedure: Office hysteroscopy and endometrial snip | Arm Label: Office hyteroscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Office hysteroscopy | Intervention Type: PROCEDURE; Name: Office hysteroscopy and endometrial snip; Assigned to Arm(s): Office hysteroscopy and endometrial snip | Intervention Type: PROCEDURE; Name: Office hysteroscopy; Assigned to Arm(s): Office hyteroscopy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fruit and Vegetable Intake Among Rural Youth Following a School-based Randomized Controlled Trial
Brief Summary: The investigators implemented a theory-based randomized controlled trial in ten rural Virginia middle schools in 2008-2010 and assessed the impact on health behaviors including fruit/vegetable intake as a primary outcome. Schools were randomized to intervention or control groups. Goal setting, peer leaders, and in-class workshops were intervention features. Seventh graders filled out surveys on health behaviors, psycho-social variables, and demographic characteristics. The investigators expected schools receiving the intervention to report a higher fruit-vegetable intake compared to control schools where students received standard health information. Sample (n=1,119) was 48.5% female, 50% White, with a mean age of 12.6 years. Fruit/vegetable intake was significantly higher in intervention schools at immediate post and at 1-year follow-up compared to controls.


Options:
A: Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Communities That Care Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communities That Care | Intervention Type: BEHAVIORAL; Name: Communities That Care; Assigned to Arm(s): Communities That Care Intervention
B: Arm Label: Fruit and Vegetable Intake Behavioral Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Fruit and vegetable intake in rural youth | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Fruit and vegetable intake in rural youth; Assigned to Arm(s): Fruit and Vegetable Intake Behavioral Intervention
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Pathways | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pathways; Assigned to Arm(s): 1
D: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: home visitation | Intervention Type: BEHAVIORAL; Name: home visitation; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fruit and Vegetable Intake Among Rural Youth Following a School-based Randomized Controlled Trial
Brief Summary: The investigators implemented a theory-based randomized controlled trial in ten rural Virginia middle schools in 2008-2010 and assessed the impact on health behaviors including fruit/vegetable intake as a primary outcome. Schools were randomized to intervention or control groups. Goal setting, peer leaders, and in-class workshops were intervention features. Seventh graders filled out surveys on health behaviors, psycho-social variables, and demographic characteristics. The investigators expected schools receiving the intervention to report a higher fruit-vegetable intake compared to control schools where students received standard health information. Sample (n=1,119) was 48.5% female, 50% White, with a mean age of 12.6 years. Fruit/vegetable intake was significantly higher in intervention schools at immediate post and at 1-year follow-up compared to controls.


Options:
A: Arm Label: learning to cope with your impulsivity; Type: EXPERIMENTAL; Interventions: Behavioral: PRE-Venture: Personality Risk Education | Arm Label: learning to cope with your sensation seeking; Type: EXPERIMENTAL; Interventions: Behavioral: PRE-Venture: Personality Risk Education | Arm Label: learning to cope with your anxiety sensitivity; Type: EXPERIMENTAL; Interventions: Behavioral: PRE-Venture: Personality Risk Education | Arm Label: learning to manage your negative thinking; Type: EXPERIMENTAL; Interventions: Behavioral: PRE-Venture: Personality Risk Education | Intervention Type: BEHAVIORAL; Name: PRE-Venture: Personality Risk Education; Assigned to Arm(s): learning to cope with your anxiety sensitivity, learning to cope with your impulsivity, learning to cope with your sensation seeking, learning to manage your negative thinking
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Adolescent Trauma Support Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Adolescent Trauma Support Program; Assigned to Arm(s): Intervention
C: Arm Label: Fruit and Vegetable Intake Behavioral Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Fruit and vegetable intake in rural youth | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Fruit and vegetable intake in rural youth; Assigned to Arm(s): Fruit and Vegetable Intake Behavioral Intervention
D: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home visitation through pregnancy; Type: EXPERIMENTAL; Interventions: Behavioral: nurse home visitation | Arm Label: Home visitation through age 2; Type: EXPERIMENTAL; Interventions: Behavioral: nurse home visitation | Intervention Type: BEHAVIORAL; Name: nurse home visitation; Assigned to Arm(s): Home visitation through age 2, Home visitation through pregnancy

Answer: C